$MDB

Cochran Hope F sold $350K of MDB

Cochran Hope F sold 1,000 shares of MongoDB, Inc. (MDB) at $350.00 ($0.35M total) on 2026-05-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cochran Hope F
Published Jun 2, 2026, 8:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MDB
Neutral
high confidence
Mentioned
$MDB
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDBNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around insider activity, but there is no new guidance, deal, or operational update in the disclosure.

02

Market read

Insider selling disclosure for MDB with 10b5-1 context; likely low incremental trading signal.

03

What to watch

Insider sales can be routine and may not correlate with near-term fundamentals; the filing size ($350K) is also relatively small versus company market value.

Relevance 7/10Novelty 6/10Timing: Filed today; sale occurred on 2026-05-29 and is disclosed with the 2026-06-02 Form 4.

Background

The article is an SEC Form 4 insider transaction: director Cochran Hope F sold 1,000 shares of MongoDB (MDB) at $350/share on 2026-05-29 via an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$MDBNeutralHigh confidence
Context

MongoDB director Cochran Hope F sold $350K of MDB shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically short-lived.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it is explicitly under a pre-arranged 10b5-1 plan and provides no new operating/financial information.

Market effects

Minimal; single-company insider sale without broader sector/regulatory developments.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled diversification rather than bearish expectations.

Key entities

  • MongoDB, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Cochran Hope F

    Director who executed the open-market sale under a 10b5-1 plan.

Related articles

$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

$MDBMedAI 9/10

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.